Abstract
Background: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.
Objective: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.
Conclusion: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.
Keywords: Clinical use, cord blood, stem cell, umblical cord blood, patent, haematology, haemopoetic diseases.
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title:Clinical Use and Patentability of Cord Blood
Volume: 11 Issue: 1
Author(s): Turker Cavusoglu*, Kubilay Dogan Kilic, Gurkan Yigitturk, Canberk Tomruk, Mehmet Turgut and Yigit Uyanikgil
Affiliation:
- Department of Histology and Embryology, Ege University School of Medicine, Izmir,Turkey
Keywords: Clinical use, cord blood, stem cell, umblical cord blood, patent, haematology, haemopoetic diseases.
Abstract: Background: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source.
Objective: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults.
Conclusion: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.
Export Options
About this article
Cite this article as:
Cavusoglu Turker *, Kilic Dogan Kubilay , Yigitturk Gurkan , Tomruk Canberk , Turgut Mehmet and Uyanikgil Yigit , Clinical Use and Patentability of Cord Blood, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2017; 11 (1) . https://dx.doi.org/10.2174/1872214812666180314121241
DOI https://dx.doi.org/10.2174/1872214812666180314121241 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Food-Derived Advanced Glycation end Products (AGEs): A Novel Therapeutic Target for Various Disorders
Current Pharmaceutical Design Effect of Microbial Transglutaminase on Protein Electrophoretic Pattern and Solubility of Wheat Flour and Hull-Less Barley Flour Blends
Current Nutrition & Food Science The Rabbit as an Experimental and Production Animal: From Genomics to Proteomics
Current Protein & Peptide Science Old Drugs for New: Contemporary Immunosuppressant Development
Medicinal Chemistry Reviews - Online (Discontinued) The Path from Anti Parkinson Drug Selegiline and Rasagiline to Multifunctional Neuroprotective Anti Alzheimer Drugs Ladostigil and M30
Current Alzheimer Research SGLT2 Inhibitors in Diabetes Mellitus Treatment
Reviews on Recent Clinical Trials Leptin as a Novel Therapeutic Target for Immune Intervention
Current Drug Targets - Inflammation & Allergy Cannabis: A Treasure Trove or Pandora's Box?
Mini-Reviews in Medicinal Chemistry Anti Inflammatory and Anti Arthritic Activity of Different Milk Based Formulation of Curcumin in Rat Model
Current Drug Delivery Current Advances in Therapy for Metastatic Melanoma
Current Cancer Therapy Reviews Gender Medicine and Pharmacoeconomics: A Narrative Review of the International Literature of the Last 5 Years. A Revision of Evidences about the Relationship Between Gender and Economic Consumption in Health
Current Pharmaceutical Design The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases – Part I
Current Medicinal Chemistry Disposition and Interaction of Biotherapeutics in Pediatric Populations
Current Drug Metabolism SGLT-2 Inhibitors: Ideal Remedy for Cardioprotection in Diabetes Mellitus
Current Molecular Pharmacology Multiplex Analysis of Cardiac Hypertrophic Signaling: Reduced in vivo Phosphorylation of Glycogen Synthase Kinase-3β and Proline-Rich Akt Substrate (PRAS40)
Current Signal Transduction Therapy Patent Selections
Recent Patents on Regenerative Medicine Integrated UPLC-MS/MS and UHPLC-Q-orbitrap HRMS Analysis to Reveal Pharmacokinetics and Metabolism of Five Terpenoids from <i>Alpiniae oxyphyllae</i> Fructus in Rats
Current Drug Metabolism Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus
Current Diabetes Reviews Origin and Biological Significance of Shed-Membrane Microparticles
Endocrine, Metabolic & Immune Disorders - Drug Targets Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions
Endocrine, Metabolic & Immune Disorders - Drug Targets